相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immunoproteasome 5i-Selective Dipeptidomimetic Inhibitors
Pradeep K. Singh et al.
CHEMMEDCHEM (2016)
Systematic Analyses of Substrate Preferences of 20S Proteasomes Using Peptidic Epoxyketone Inhibitors
Eva M. Huber et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
Eoin F. McKinney et al.
NATURE (2015)
Selective immunoproteasome inhibitors with non-peptide scaffolds identified from structure-based virtual screening
Vinod Kasam et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Michael Basler et al.
EMBO MOLECULAR MEDICINE (2014)
A draft map of the human proteome
Min-Sik Kim et al.
NATURE (2014)
Mass-spectrometry-based draft of the human proteome
Mathias Wilhelm et al.
NATURE (2014)
Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection
Bara Sarraj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Oxathiazolones Selectively Inhibit the Human Immunoproteasome over the Constitutive Proteasome
Hao Fan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Coinhibitory receptors and CD8 T cell exhaustion in chronic infections
Vijay K. Kuchroo et al.
CURRENT OPINION IN HIV AND AIDS (2014)
N,C-Capped Dipeptides with Selectivity for Mycobacterial Proteasome over Human Proteasomes: Role of S3 and S1 Binding Pockets
Gang Lin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells
H. Travis Ichikawa et al.
ARTHRITIS AND RHEUMATISM (2012)
Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity
Eva M. Huber et al.
CELL (2012)
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
Ben Gold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis
Makiko Hirai et al.
BLOOD (2011)
In vitro differentiation of human macrophages with enhanced antimycobacterial activity
Guillaume Vogt et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit
Christopher Blackburn et al.
BIOCHEMICAL JOURNAL (2010)
Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome
Michael Basler et al.
JOURNAL OF IMMUNOLOGY (2010)
Inhibitors selective for mycobacterial versus human proteasomes
Gang Lin et al.
NATURE (2009)
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
Tony Muchamuel et al.
NATURE MEDICINE (2009)
Selective killing of nonreplicating mycobacteria
Ruslana Bryk et al.
CELL HOST & MICROBE (2008)
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
Kirsten Neubert et al.
NATURE MEDICINE (2008)
Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy
A. L. Goldberg
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation
Cristiana Guiducci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)